Accepted answer
Worth being precise here: the honest answer is that the achievable range of plausible purity figures for a given vial is wider than most people expect.
Sample solvent strength affects peak shape — if you inject in strong solvent on a gradient starting in weak solvent, the solvent peak can distort your main peak or create a false shoulder.
On the detail: integration of the shoulder — whether you use perpendicular drop or tangent skim — determines what area gets assigned to the main peak versus the impurity table.
Inter-laboratory studies on identical peptide material routinely find half-a-per-cent to a full-per-cent spreads in reported purity on the same sample.
Worth noting that method standardisation is poor in the research-grade space compared to pharmaceutical work, so identical-looking methods can produce different results.
If you are ranking vendors, specify a method and have all samples tested at the same place.
edited 19 Apr 2026 by lipid_panel_q — fixed an arithmetic slip in the third paragraph
5Thank you — the worked example is what makes this usable. – tyndall_haze 4 months ago 6Related: the same reasoning applies to the counter-ion question. – tare_weight 6 months ago add a comment